What is the Normal Dosage of Ozempic for Weight Loss?

Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist, has revolutionized weight loss treatment by reducing appetite and improving blood sugar control. The medication is typically started at a low dose and increased gradually every four weeks until reaching an effective therapeutic level. Understanding how dosing works can help you set realistic expectations for your weight loss journey with PlexusDx.

How Semaglutide Dosing Works for Weight Loss

Semaglutide treatment begins with a 0.25 mg injection once weekly, the lowest starting dose that minimizes gastrointestinal side effects while allowing your body to adapt to the medication. Most people tolerate this initial phase well, experiencing early appetite suppression and improved satiety at meals. After four weeks, the dose increases to 0.5 mg weekly, then continues escalating by 0.25 mg increments every four weeks until reaching a maintenance dose.

The typical maintenance dose for weight loss ranges from 1.0 mg to 2.4 mg injected once per week, though individual needs vary based on body composition, metabolic factors, and response patterns. Your PlexusDx clinician adjusts your dose based on clinical progress and tolerability rather than a rigid protocol. The goal is finding your effective dose—the lowest amount that produces meaningful weight loss without unwanted effects.

Standard Semaglutide Weight Loss Dosing Schedule

The FDA-studied dosing sequence for weight management follows this timeline: Week 1-4 at 0.25 mg, Week 5-8 at 0.5 mg, Week 9-12 at 1.0 mg, and Week 13+ at 1.7 mg or 2.4 mg as tolerated. Clinical trials show that participants reaching 2.4 mg per week experienced an average weight reduction of 15% of their body weight over 68 weeks. However, meaningful weight loss often occurs at lower doses (0.5-1.0 mg), and some individuals achieve their goals without escalating to the maximum dose.

PlexusDx does not increase your monthly cost when your dose increases—your price remains flat regardless of which dose level you're using. This approach removes financial barriers to finding your optimal therapeutic dose. Your clinician may recommend holding at a particular dose if you're experiencing good results, or they may pause escalation if side effects warrant stabilization.

Factors That Influence Your Semaglutide Dose

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Your starting weight, age, kidney function, gastrointestinal tolerance, and concurrent medications all influence how quickly your dose escalates and where it plateaus. People with a higher baseline weight may require higher doses for equivalent weight loss percentages. Additionally, if you experience nausea, constipation, or other side effects, your clinician may extend the time between dose increases or maintain a lower dose for longer.

Semaglutide Weight Loss Results Across Dose Levels

Clinical evidence demonstrates dose-dependent weight loss: at 0.5 mg weekly, participants lost approximately 4-5% of body weight; at 1.0 mg, losses averaged 7-9%; and at 2.4 mg, average weight reduction reached 14-15% over the study period. However, these represent group averages—individual results vary substantially based on adherence, diet, exercise, and personal metabolism. Some patients plateau at lower doses and see no additional benefit from escalation, while others require the maximum dose for optimal results.

The first four weeks typically show modest changes as your appetite decreases and portion sizes naturally shrink. Weeks 5-12 often bring accelerated weight loss as your dose increases and metabolic adaptation occurs. After three to four months of consistent treatment, your rate of weight loss may slow, which is normal physiology—your body adapts to the medication's appetite-suppressing effects.

When to Consider Dose Adjustments with PlexusDx

Your PlexusDx clinician may recommend dose adjustments based on your progress at regularly scheduled check-ins. If you're experiencing significant nausea or vomiting that interferes with eating or nutrition, your dose may be held at its current level or reduced to allow symptom resolution. Conversely, if you've been stable at a particular dose for 4-6 weeks without notable weight loss or appetite suppression, a dose increase may be warranted.

PlexusDx provides injectable and oral semaglutide formulations, each with its own dosing profile—oral versions typically use higher dose strengths (7 mg, 14 mg) compared to weekly injections (0.25-2.4 mg). Your clinician helps select the formulation that best suits your lifestyle and absorption patterns. The monthly cost of your compounded semaglutide remains consistent at $189/month regardless of dose escalation.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?

Semaglutide for weight loss starts at 0.25 mg injected once weekly, the lowest dose that allows your body to adjust while minimizing side effects. PlexusDx prescribers begin all patients at this dose, then escalate gradually every four weeks based on tolerance and clinical response.

What is the maximum dose of semaglutide approved for weight loss?

The maximum studied dose for weight management is 2.4 mg injected once weekly. However, clinical trials show meaningful weight loss occurs at lower doses (1.0-1.7 mg), and many patients achieve their goals without escalating to the highest dose.

Does my PlexusDx price increase if my dose goes up?

No. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and remain that price regardless of your dose level. Your dose may increase as your treatment progresses, but your monthly cost stays flat.

How quickly should semaglutide doses increase?

Standard escalation increases your dose by 0.25 mg every four weeks (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg). Your PlexusDx clinician may adjust this timeline if you need more time to tolerate side effects or if you reach your weight loss goal at a lower dose.

Can genetic testing help determine my ideal semaglutide dose?

Yes. The PlexusDx Precision Peptide Genetic Test identifies variants in your GIPR, FTO, and MC4R genes that influence how effectively semaglutide works at different doses. This genetic insight helps your clinician personalize your dosing strategy and provide pathway-level context (it does not predict your response).

What if my nausea is severe at my current semaglutide dose?

Nausea typically resolves within 3-7 days as your body adapts. If it persists or interferes with eating, your PlexusDx clinician may pause dose escalation, reduce your dose temporarily, or recommend dietary adjustments. Severity of nausea does not correlate with weight loss effectiveness.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Glp 1 Dosage For Weight Loss
• Weight Loss Drugs Like Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.